The reason behind the high inter-individual variability in response to SARS-CoV-2 infection
and patient's outcome is poorly understood. The present study targets the sphingolipid …

COVID-19 pandemic exerts a health care emergency around the world. The illness severity
is heterogeneous. It is mostly unknown why some individuals who are positive for SARS …

Background A heterogeneous clinical phenotype is a characteristic of coronavirus disease
2019 (COVID‐19). Therefore, investigating biomarkers associated with disease severity is …

Understanding pathways that might impact coronavirus disease 2019 (COVID-19)
manifestations and disease outcomes is necessary for better disease management and for …

Although the serum lipidome is markedly affected by COVID-19, two unresolved issues
remain: how the severity of the disease affects the level and the composition of serum lipids …

Introduction The SARS-CoV-2 mediated COVID-19 pandemic has impacted millions
worldwide. Hyper-inflammatory processes, including cytokine storm, contribute to long …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-
19 pandemic with severe consequences for afflicted individuals and the society as a whole …

Introduction: Similar to what it has been reported with preceding viral epidemics (such as
MERS, SARS, or influenza), SARS-CoV-2 infection is also affecting the human …

Background: Coronavirus-19 (COVID-19) pandemic is a worldwide public health problem
that has been known in China since December 25, 2019. Phospholipids are structural …

Sphingolipids are potent bioactive agents involved in the pathogenesis of various
respiratory bacterial infections. To date, several sphingolipid derivatives are known, but S1P …